Nigel Theobald

Nigel Theobald, Chief Executive Officer at N4 Pharma, has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network covering all aspects of pharmaceutical product development and commercialization.

Content by Nigel Theobald:

Subspecialties Glaucoma

A Novel Approach to Preventing Fibrosis Post-Glaucoma Surgery

12/09/2024 | Nigel Theobald | 5 min read

Outlining the promise siRNA gene silencing

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Ophthalmologist magazine

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: